←Back to Expert Scholars
Translational Medicine / 转化医学HER2 NSCLC, EGFR Resistance
Helena Yu
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Associate Attending Physician
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Helena Yu is a thoracic oncologist focused on HER2 mutant and EGFR mutant lung cancer. She has contributed to major clinical trials of trastuzumab deruxtecan and other HER2 targeted agents in NSCLC. Her translational work elucidates mechanisms of response and resistance to HER2 directed ADCs.
Share:
🧪Research Fields 研究领域
HER2 exon 20 insertion
NSCLC
targeted therapy
ADC
resistance mechanisms
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Helena Yu 的研究动态
Follow Helena Yu's research updates
留下邮箱，当我们发布与 Helena Yu（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment